Evidence map›Paper›PMID 38396892›Full record

ArticleInternational journal of molecular sciences2024

Antibiotic Combination to Effectively Postpone or Inhibit the In Vitro Induction and Selection of Levofloxacin-Resistant Mutants in

Ching-Chi Lee, Chung-Hsu Lai, Chih-Hui Yang, Yi-Han Huang, Jiun-Nong Lin

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.9field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Pathogens (Basel, Switzerland) · 2026
    Review
  2. Case Report: A neonatal case ofFrontiers in pediatrics · 2026
    Article
  3. Article
  4. Severe pneumonia caused byAmerican journal of translational research · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ching-Chi LeeClinical Medical Research Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.ORCID 0000-0002-4949-2742
Chung-Hsu LaiSchool of Medicine, College of Medicine, I-Shou University, Kaohsiung 824, Taiwan.
Chih-Hui YangDepartment of Biological Science and Technology, Meiho University, Pingtung 912, Taiwan.
Yi-Han HuangSchool of Medicine, College of Medicine, I-Shou University, Kaohsiung 824, Taiwan.
Jiun-Nong LinSchool of Medicine, College of Medicine, I-Shou University, Kaohsiung 824, Taiwan.ORCID 0000-0002-4417-5350
E-Da Hospital · TWMeiho University · TWNational Cheng Kung University Hospital · TW

Funding

E-Da Hospital EDPJ111057Ministry of Science and Technology MOST 111-2314-B-214-006National Cheng Kung University Hospital NCKUH-11210024National Cheng Kung University Hospital NCKUH-11304002National Cheng Kung University Hospital NCKUH-11310024
6 · The paper itself

Abstract

Fluoroquinolones are potentially active against

Indexed as

FlavobacteriaceaeLevofloxacinMinocyclineAnti-Bacterial AgentsDNA GyraseDrug Resistance, BacterialFluoroquinolonesMicrobial Sensitivity TestsMutationSulfamethoxazoleTrimethoprimAnti-Bacterial AgentsDNA GyraseFluoroquinolonesLevofloxacinMinocyclineSulfamethoxazoleTrimethoprimcombination therapyElizabethkingia anophelisfluoroquinolonequinolone resistance-determining region

Identifiers

PMID38396892
PMCPMC10889675
OpenAlexW4391755448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.